*Epidemiology of Histoplasmosis DOI: http://dx.doi.org/10.5772/intechopen.110901*

[32] Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. The American Review of Respiratory Disease. 1969;**99**(4):1-132

[33] Kwon-Chung KJ. Sexual stage of *Histoplasma capsulatum*. Science. 1972;**175**(4019):326. DOI: 10.1126/ science.175.4019.326

[34] Kwon-Chung KJ. Emmonsilla capsulata: Perfect state of *Histoplasma capsulatum*. Science. 1972;**177**(4046):368-369. DOI: 10.1126/ science.177.4046.368

[35] Hwang L, Hocking-Murray D, Bahrami AK, Andesson M, Rine J, Sil A. Identifying phase-specific genes in the fungal pathogen *Histoplasma capsulatum* using a genomic shotgun microarray. Molecular Biology of the Cell. 2003;**14**(6):2314-2326. DOI: 10.1091/ mbc.e03-01-0027

[36] Kasuga T, White TJ, Koenig G, McEwen J, Restrepo A, Castañeda E, et al. Phylogeography of the fungal pathogen *Histoplasma capsulatum*. Molecular Ecology. 2003;**12**(12):3383-3401. DOI: 10.1046/j.1365-294x.2003.01995.x

[37] Whitt SP, Koch GA, Fender B, Ratnasamy N, Everett ED. Histoplasmosis in pregnancy: Case series and report of transplacental transmission. Archives of Internal Medicine. 2004;**164**(4):454-458. DOI: 10.1001/archinte.164.4.454

[38] Damasceno LS, Vite-Garín T, Ramírez JA, Rodríguez-Arellanes G, Almeida MAD, Muniz MDM, et al. Mixed infection by *Histoplasma capsulatum* isolates with different mating types in Brazilian AIDS-patients. Revista do Instituto de Medicina Tropical de São Paulo. 2019;**61**. Article number: e8. DOI: 10.1590/s1678-9946201961008

[39] Moreira LM, Meyer W, Chame M, Brandão LM, Vivoni AM, Portugal J, et al. Molecular detection of *Histoplasma capsulatum* in Antarctica. Emerging Infectious Diseases. 2022;**28**(10):2100- 2104. DOI: 10.3201/eid2810.220046

[40] The WHO lists multiple fungal pathogens of critical, high and medium importance for addressing with R&D, surveillance and access to diagnosis and treatment. 2022. Available from: https:// gaffi.org/wp-content/uploads/WHO-FPPL-2022.pdf. [Accessed: 2023-03-03]

[41] Beyhan S, Sil A. Sensing the heat and the host: Virulence determinants of *Histoplasma capsulatum*. Virulence. 2019;**10**:793-800. DOI: 10.1080/21505594.2019.1663596

[42] Edwards JA, Rappleye CA. Histoplasma mechanisms of pathogenesis - one portfolio doesn't fit all. FEMS Microbiology Letters. 2011;**324**:1-9. DOI: 10.1111/j.1574-6968. 2011.02363.x

[43] Lockhart SR, Toda M, Benedict K, Caceres DH, Litvintseva AP. Endemic and other dimorphic mycoses in the Americas. Journal of Fungi. 2021;**7**(2):151. DOI: 10.3390/jof7020151

[44] Scully MC, Baddley JW. Epidemiology of histoplasmosis. Current Fungal Infection Reports. 2018;**12**:51-58. DOI: 10.1007/s12281-018-0309-x

[45] Damasceno LS, Teixeira MM, Barker BM, Almeida MA, Muniz MM, Pizzini CV, et al. Novel clinical and dual infection by *Histoplasma capsulatum* genotypes in HIV patients from Northeastern, Brazil. Scientific Reports. 2019;**9**(1):11789. DOI: 10.1038/ s41598-019-48111-6

[46] Diaz JH. Environmental and wilderness-related risk factors for histoplasmosis: More than bats in caves. Wilderness & Environmental Medicine. 2018;**29**(4):531-540. DOI: 10.1016/j. wem.2018.06.008

[47] Vite-Garín T, Estrada-Bárcenas DA, Cifuentes J, Taylor ML. The importance of molecular analyses for understanding the genetic diversity of *Histoplasma Capsulatum*: An overview. Revista Iberoamericana de Micología. 2014;**31**(1):11-15. DOI: 10.1016/j. riam.2013.09.013

[48] Kauffman CA. Histoplasmosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. 2nd ed. New-York: Springer Science + Business Media LLC; 2011. pp. 321-336. DOI: 10.1007/978-1-4419-6640-7\_18

[49] Deepe GS. *Histoplasma capsulatum* (Histoplasmosis). In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020. pp. 3162-3176

[50] Kwon-Chung KJ. Perfect state (Emmonsiella capsulata) of the fungus causing large-form African histoplasmosis. Mycologia. 1975;**67**(5):980-990. DOI: 10.1080/ 00275514.1975.12019831

[51] Kwon-Chung KJ, Weeks RJ, Larsh HW. Studies on Emmonsiella capsulata (*Histoplasma capsulatum*). II. Distribution of the two mating types in 13 endemic states of the United States. American Journal of Epidemiology. 1974;**99**(1):44-49. DOI: 10.1093/ oxfordjournals.aje.a121583

[52] Rodrigues AM, Beale MA, Hagen F, Fisher MC, Terra PPD, de Hoog S, et al. The global epidemiology of emerging Histoplasma species in recent years. Studies in Mycology. 2020;**97**:100095. DOI: 10.1016/j.simyco.2020.02.001

[53] Voorhies M, Foo CK, Sil A. Experimental annotation of the human pathogen *Histoplasma capsulatum* transcribed regions using high-resolution tiling arrays. BMC Microbiology. 2011;**11**:216. DOI: 10.1186/1471-2180-11-216

[54] Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. *Histoplasma capsulatum*: Mechanisms for pathogenesis. Current Topics in Microbiology and Immunology. 2019;**422**:157-191. DOI: 10.1007/82\_2018\_114

[55] Vincent RD, Goewert R, Goldman WE, Kobayashi GS, Lambowitz AM, Medoff G. Classification of *Histoplasma capsulatum* isolates by restriction fragment polymorphisms. Journal of Bacteriology. 1986;**165**(3):813- 818. DOI: 10.1128/jb.165.3.813.1986

[56] Spitzer ED, Lasker BA, Travis SJ, Kobayashi GS, Medoff G. Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of *Histoplasma capsulatum*. Infection and Immunity. 1989;**57**(5):1409-1412. DOI: 10.1128/ iai.57.5.1409-1412.1989

[57] Keath EJ, Kobayashi GS, Medoff G. Typing of *Histoplasma capsulatum* by restriction fragment length polymorphisms in a nuclear gene. Journal of Clinical Microbiology. 1992;**30**(8):2104-2107. DOI: 10.1128/ jcm.30.8.2014-2017.1992

[58] Teixeira MM, Patané JS, Taylor ML, Gómez BL, Theodoro RC, de Hoog S, et al. Worldwide phylogenetic distributions and population dynamics of the genus Histoplasma. PLOS Neglected Tropical Diseases. 2016;**10**(6):e0004732. DOI: 10.1371/joutnal.pntd.0004732

[59] Sepúlveda VE, Márquez R, Turissini DA, Goldman WE. Matute DR, *Epidemiology of Histoplasmosis DOI: http://dx.doi.org/10.5772/intechopen.110901*

Genome sequences reveal cryptic speciation in the human pathogen *Histoplasma capsulatum*. MBio. 2017;**8**(6):e01339-e01317. DOI: 10.1128/ mBio.01339-17

[60] Davis TE, Domer JE, Li YT. Cell wall studies of *Histoplasma capsulatum* and Blastomyces dermatitis using autologous and heterologous enzymes. Infection and Immunity. 1977;**15**(3):978-987. DOI: 10.1128/iai.15.3.978-987.1977

[61] Howarth MC, Fecher RA, Deepe GS. *Histoplasma capsulatum*, lung infection and immunity. Future Microbiology. 2015;**10**:967-975. DOI: 10.2217/fmb.15.25

[62] Ray SC, Rappleye CA. Flying under the radar: *Histoplasma capsulatum* avoidance of innate immune recognition. Seminars in Cell & Developmental Biology. 2019;**89**:91-98. DOI: 10.1016/j. semcdb.2018.03.009

[63] Denham ST, Wambaugh MA, Brown JCS. How environmental fungi cause a range of clinical outcomes in susceptible hosts. Journal of Molecular Biology. 2019;**431**:2982-3009. DOI: 10.1016/j.jmb.2019.05.003

[64] Sil A. Using genomics to study the life cycle of *Histoplasma capsulatum*. In: AJP B, editor. Fungal Genomics. Berlin Heidelberg: Springer-Verlag; 2006. pp. 221-236. DOI: 10.1007/3-540-30809-1\_12

[65] Okansey BK, Kosmidis C, Agyei M, Dorkenoo AM, Ayanlowo OO, Oladele RO, et al. Histoplasmosis in Africa: Current perspectives, knowledge gaps, and research priorities. PLOS Neglected Tropical Diseases. 2022;**16**(2):e0010111. DOI: 10.1371/ journal.pntd.0010111

[66] de Perio MA, Benedict K, Williams SL, Niemeier-Walsh C, Green BJ, Coffey C, et al. Occupational histoplasmosis: Epidemiology and prevention measures. Journal of Fungi (Basel). 2021;**7**(7):510-522. DOI: 10.3390/ jof7070510

[67] Guimarães AJ, de Cerqueira MD, Nosanchuk JD. Surface architecture of *Histoplasma capsulatum*. Frontiers in microbiology. 2011;**2**:225. DOI: 10.3389/ fmicb.2011.00225

[68] Linder KA, Kauffman CA. Histoplasmosis: Epidemiology, diagnosis, and clinical manifestations. Current Fungal Infection Reports. 2019;**13**:120- 128. DOI: 10.1007/s12281-019-00341-x

[69] Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: Thinking outside of the Ohio river valley. Current Tropical Medicine Reports. 2015;**2**(2):70-80. DOI: 10.1007/ s40475-015-0044-0

[70] Benedict K, Derado G, Mody RK. Histoplasmosis-associated hospitalizations in the United States, 2001-2012. Open Forum Infectious Diseases. 2016;**3**(1):ofv219. DOI: 10.1093/ ofid/ofv219

[71] Azar MM, Hage CA. Clinical perspectives in the diagnosis and management of histoplasmosis. Clinics in Chest Medicine. 2017;**38**(3):403-415. DOI: 10.1016/j.ccm.2017.04.004

[72] Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-γ receptor 1 deficiency. Clinical Infectious Diseases. 2005;**41**(4):38-41. DOI: 10.1086/432120

[73] Taylor ML, Pérez-Mejía A, Yamamoto-Furusho JK, Granados J. Immunologic, genetic and social human risk factors associated to histoplasmosis: Studies in the state of Guerrero. Mexico. Mycopathologia. 1997;**138**(3):137-142. DOI: 10.1023/a:1006847630347

[74] Benedict K, Thompson GR 3rd, Deresinski S, Chiller T. Mycotic infections acquired outside areas of known endemicity, United States. Emerging Infectious Disease. 2015;**21**(11):1935-1941. DOI: 10.3201/ eid2111.141950

[75] Taylor ML, Reyes-Montes MDR, Estrada-Barcenas DA, Zancopé-Oliveira RM, Rodríguez-Arellanes G, Ramírez JA. Considerations about the geographic distribution of Histoplasma species. Applied and Environmental Microbiology. 2022;**88**(7):e0201021. DOI: 10.1128/aem.02010-21

[76] Ajello L. Relationship of *Histoplasma capsulatum* to avian habitats. Public Health Reports. 1964;**79**(3):266-270

[77] Deepe GS Jr. Outbreaks of histoplasmosis: The spores set sail. PLoS Pathogens. 2018;**14**(9):e1007213. DOI: 10.1371/journal.ppat.1007213

[78] Benito N, García Vázquez E, Blanco A, de Górgolas M, Gadea I, Escalonilla P, et al. Histoplasmosis diseminada en pacientes con sida. Estudio de 2 casos y revisión de la bibliografía española Disseminated histoplasmosis in AIDS patients. A study of 2 cases and review of the Spanish literature. Enfermedades Infecciosas y Microbiologia Clinica. 1998;**16**(7):316-321

[79] Gómez Londoño LF, Pérez León LC, Mcewen Ochoa JG, Zuluaga Rodriguez A, Peláez Jaramillo CA, Acevedo Ruiz JM, et al. Capacity of *Histoplasma capsulatum* to survive the composting process. Applied and Environmental Soil Science. 2019;**2019**:1-9. DOI: 10.1155/2019/5038153

[80] Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, et al. Vertical transmission of histoplasmosis associated with

anti-tumor necrosis factor therapy. Journal of the Pediatric Infectious Disease. 2016;**5**(2):e19-e12. DOI: 10.1093/ jpids/piw001

[81] Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. American Journal of Transplantation. 2011;**11**:1123-1130. DOI: 101111/j.1600-6143.2011.03493.x

[82] Limaye AP, Connolly PA, Sagar M, Fritsche TR, Cookson BT, Wheat LJ, et al. Transmission of *Histoplasma capsulatum* by organ transplantation. The New England Journal of Medicine. 2000;**343**(16):1163-1166. DOI: 10.1056/ NEJM200010193431605

[83] Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clinical Infectious Diseases. 2009;**49**(5):710-716. DOI: 10.1086/604712

[84] Loulergue P, Bastides F, Baudouin V, Chandenier J, Mariani-Kurkdjian P, Dupont B, et al. Literature review and case histories of *Histoplasma capsulatum* var. duboisii infections in HIV-infected patients. Emerging Infectious Diseases. 2007;**13**(11):1647-1652. DOI: 10.3201/ eid1311.070665

[85] Terrancle JI, Mateos RF, Solera SJ, Sánchez HV. Disseminated histoplasmosis in two brothers with AIDS. Revista Clinica Española. 2004;**204**(7):381-383. DOI: 10.1157/13063533

[86] Metzler DF, Ritter C, Culp RL. Combined effect of water purification processes on the removal of *Histoplasma capsulatum* from water. American Journal of Public Health and the Nations Health. 1956;**46**:1571-1575. DOI: 10.2105/ ajph.46.12.1571

*Epidemiology of Histoplasmosis DOI: http://dx.doi.org/10.5772/intechopen.110901*

[87] Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate epidemiology of histoplasmosis, United States, 2011- 2014. Emerging Infectious Diseases. 2018;**24**(3):425-431. DOI: 10.3201/ eid2403.171258

[88] Adenis AA, Aznar C, Couppié P. Histoplasmosis in HIV-infected patients: A review of new developments and remaining gaps. Current Tropical Medicine Reports. 2014;**1**(2):119-128. DOI: 10.1007/s40475-014-0017-8

[89] Wheat LJ. Histoplasmosis: A review for clinicians from non-endemic areas. Mycoses. 2006;**49**(4):274-282. DOI: 10.1111/j.1439-0507.2006.01253.x

[90] Benedict K, Mody RK. Epidemiology of histoplasmosis outbreaks, United States, 1938-2013. Emerging Infectious Diseases. 2016;**22**(3):370-378. DOI: 10.3201/eid2203.151117

[91] Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. Neglected endemic mycoses. The Lancet Infectious Diseases. 2017;**17**(11):e367-e377. DOI: 10.1016/ S1473-3099(17)30306-7

[92] Kauffman CA. Histoplasmosis: A clinical and laboratory update. Clinical Microbiology Reviews. 2007;**20**(1):115- 132. DOI: 10.1128/CMR.00027-06

[93] Smith DJ, Williams SL, Endemic Mycoses State Partners Group, Benedict KM, Jackson BR, Toda M. Surveillance for Coccidioidomycosis, histoplasmosis, and Blastomycosis - United States, 2019. MMWR Surveillance Summaries. 2022;**71**(7):1-14. DOI: 10.15585/mmwr.ss7107a1

[94] Ashraf N, Kubat RC, Poplin V, Adenis AA, Denning DW, Wright L, et al. Re-drawing the maps for endemic mycoses. Mycopathologia. 2020;**185**:843- 865. DOI: 10.1007/s11046-020-00431-2

[95] Burden of common life-threatening fungal infections. Available from: https:// gaffi.org/why/fungal-disease-frequency/ [Accessed: 2023-03-03]

[96] Centers for Disease Control (CDC). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Supplements. 1987;**36**(1):1S-15S

[97] Martin-Iguacel R, Kurtzhals J, Jouvion G, Nielsen SD, Llibre JM. Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review. Infection. 2014;**42**:611-620. DOI: 10.1007/s15010-014-0611-7

[98] Baker J, Setianingrum F, Wahyuningsih R, Denning DW. Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS. Emerging Microbes & Infections. 2019;**8**(1):1139-1145. DOI: 10.1080/22221751.2019.1644539

[99] McLeod DSA, Mortimer RH, Perry-Keene DA, Allworth A, Woods ML, Perry-Keene J, et al. Histoplasmosis in Australia: Report of 16 cases and literature review. Medicine (Baltimore). 2011;**90**(1):61-68. DOI: 10.1097/ MD.0b013e318206e499

[100] Hepler SA, Kaufeld KA, Benedict K, Toda M, Jackson BR, Liu X, et al. Integrating public health surveillance and environmental data to model presence of Histoplasma in the United States. Epidemiology. 2022;**33**(5):654-659. DOI: 10.1097/EDE.0000000000001499

[101] Manos NE, Ferebee SH, Kerschbaum WF. Geographic variation in the prevalence of histoplasmin sensitivity. Diseases of the Chest. 1956;**29**(6):649- 668. DOI: 10.1378/chest.29.6.649

[102] Cherabie J, Mazi P, Rauseo AM, Ayres C, Larson L, Rutjanawech S, et al. Long-term mortality after Histoplasma infection in people with HIV. Journal of Fungi. 2021;**7**(5):369. DOI: 10.3390/ jof7050369

[103] Brown EM, McTaggart LR, Dunn D, Pszczolko E, Tsui KG, Morris SK, et al. Epidemiology and geographic distribution of blastomycosis, histoplasmosis, and coccidioidomycosis, Ontario, Canada, 1990-2015. Emerging Infectious Diseases. 2018;**24**(7):1257- 1266. DOI: 10.3201/eid2407.172063

[104] Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: A modeling study. The Lancet Infectious Diseases. 2018;**18**(10):1150-1159. DOI: 10.1016/ S1473-3099(18)30354-2

[105] Nacher M, Leitao TS, Gómez BL, Couppié P, Adenis A, Damasceno L, et al. The fight against HIV-associated disseminated histoplasmosis in the Americas: Unfolding the different stories of four centers. Journal of Fungi. 2019;**5**(2):51. DOI: 10.3390/jof5020051

[106] Samayoa B, Roy M, Cleveland AA, Medina N, Lau-Bonilla D, Scheel CM, et al. High mortality and coinfection in a prospective cohort of human immunodeficiency virus/acquired immune deficiency syndrome patients with histoplasmosis in Guatemala. The American Journal of Tropical Medicine Hygiene. 2017;**97**(1):42-48. DOI: 10.4269/ajtmh.16-000

[107] Agudelo CA, Restrepo CA, Molina DA, Tobón AM, Kauffman CA, Murillo C,

et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. The American Journal of Tropical Medicine Hygiene. 2012;**87**(6):1094-1098. DOI: 10.4269/ajtmh.2012.12-0292

[108] Medina N, Alastruey-Izquierdo A, Bonilla O, Gamboa O, Mercado D, Pérez JC, et al. A rapid screening program for histoplasmosis, tuberculosis, and cryptococcosis reduces mortality in HIV patients from Guatemala. Journal of Fungi. 2021;**7**(4):268. DOI: 10.3390/jof7040268

[109] Medina N, Rodriguez-Tudela JL, Aguirre L, Salazar LR, Gamboa O, Bonilla O, et al. Incidence of histoplasmosis in a cohort of people with HIV: From estimations to reality. Microorganisms. 2021;**9**(12):2596. DOI: 10.3390/ microorganisms9122596

[110] Nacher M, Adenis A, Guarmit B, Lucarelli A, Blanchet D, Demar M, et al. What is AIDS in the Amazon and the Guianas in the 90-90-90 era? PLoS One. 2020;**15**(7):e0236368. DOI: 10.1371/ journal.pone.0236368

[111] Almeida MA, Almeida-Silva F, Guimarães AJ, Almeida-Paes R, Zancopé-Oliveira RM. The occurrence of histoplasmosis in Brazil: A systematic review. International Journal of Infectious Diseases. 2019;**86**:147-156. DOI: 10.1016/j.ijid.2019.07.009

[112] Brilhante RS, Fechine MA, Mesquita JR, Cordeiro RA, Rocha MFG, Monteiro AJ, et al. Histoplasmosis in HIV-positive patients in Ceará, Brazil: Clinical-laboratory aspects and in vitro antifungal susceptibility of *Histoplasma capsulatum* isolates. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012;**106**(8):484-488. DOI: 10.1016/j.trstmh.2012.05.003

[113] Oladele RO, Ayanlowo OO, Richardson MD, Denning DW.
